Archive: News
-
Dr. Marcus S. Noel Joins the GI Team at Georgetown Lombardi Comprehensive Cancer Center
This week Marcus S. Noel, MD joined the Georgetown Lombardi Comprehensive Cancer Center as Associate Professor of Medicine and Co-Director, Clinical Research Management Office, both within the D
Category: News
-
Katie Couric is the Inaugural Speaker at Georgetown’s Edward M. Kovach Cura Personalis Endowed Lecture
Katie Couric and John Marshall, MD, discuss the importance of communications among doctors, patients and caregivers during the Inaugural Edward M. Kovach Cura Personalis Endowed Lecture at Lohrfink Auditorium, Georgetown University. “It makes a huge difference for patients and their families to have caring, compassionate doctors,” explained Couric.
Category: News
-
Ruesch Center Summer Interns Complete Another Successful Year
Aspiring medical students Antara Sarkar and Richard Shin participated in this year’s summer internship program at Georgetown University’s Ruesch Center.
Category: News
-
A Sabbatical Just What the Doctor Ordered
“I’ve realized over the last few years that if I’m going to be a good physician for another 10 to 15 years, I need to take a break now,” says medical oncologist John Marshall, MD, a 31-year veteran of Georgetown.
Category: News
-
Former News4 Anchor Joe Krebs Doing Well in Fight Against Pancreatic Cancer
Former News4 anchor Joe Krebs has been fighting pancreatic cancer for almost two years. This video highlights his treatment at Lombardi Comprehensive Cancer Center with Dr. John L. Marshall.
Category: News
-
Second-leading cancer killer on the rise in young adults
Dr. John Marshall talks with 7 On Your Side WJLA-TV, about Colon Cancer on the rise in young adults.
Category: News
-
When you have stage 4 cancer, the shutdown is about more than a missed paycheck
A federal employee with colon cancer grapples with complicated insurance problems as a result of the partial government shutdown.
Category: News
-
Genomic and Transcriptomic Profiling Finds Potential Predictors and Therapeutic Targets in Pancreatic Cancer
Dr. Michael Pishvaian’s talk on the prognostic value of HR-DDR mutations in Pancreatic Cancer from ASCO GI is highlighted in ASCO Daily News.
Category: News
-
Immunotherapy Could Have Role in Frontline HCC
In the search to establish new therapeutic options for patients with advanced hepatocellular carcinoma (HCC), immunotherapy has become a frontrunner in many clinical trials in the first-line setting, according to Michael J. Pishvaian, MD, PhD.
Category: News
-
Looking for Zebras in Metastatic Colorectal Cancer
Although colorectal cancer is one of the most commonly diagnosed cancers in the United States,1 and researchers’ understanding of the biology and pathophysiology of CRC has grown, its many variations require that each case be diagnosed with care.
Category: News